Hair + Nails Reality Check Stack

Public • 2/4/2026

Minimalist approach that focuses on likely gaps and avoids mega-dosing trends.

← Back Buy stack

Practical pre-check

Deterministic heuristics (stimulants, duplicates, hydration). Not medical advice.

Supplements

Items in this stack

Training load

Unknown load

Need more wearable data

Stimulant estimate

0 mg

Only counts explicit caffeine items

Looks clean

No obvious duplication/stimulant/hydration flags from the heuristic pass.

AI risk assessment

Context: No wearable data

No assessment yet.

Supplements

3 items

Biotin (Vitamin B7)Low

With breakfast • Capsule • Click to expand

Only strong rationale in deficiency contexts; keep dose conservative and disclose before lab tests.

Buy ingredient →

2mg

Hair/nail claims and evidence quality

Low

Population: General population

Study type: Government evidence review

Dose context: — (range: 0–5 mg) • Duration: Varies

ODS notes hair/nail claims are supported at best by small studies and case reports; highlights deficiency contexts.

Citation: NIH ODS – Biotin: Health Professional Fact Sheet•https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/

Immunoassay interference (thyroid and other tests)

Moderate

Population: Individuals taking high-dose biotin supplements

Study type: Review / safety analysis

Dose context: 10 mg typical (range: 5–100 mg) • Duration: Acute (single dose effect on assays)

High-dose biotin (≥5 mg/day) can cause falsely elevated or depressed results in streptavidin-biotin immunoassays including thyroid hormones (TSH, fT4, fT3), troponin, and other common panels. Biotin should be withheld 48–72 hours before testing.

Citation: Samarasinghe S, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocr Pract. 2017;23(8):989-998.•https://pubmed.ncbi.nlm.nih.gov/28534685/

Vitamin CModerate

With food • Capsule • Click to expand

General micronutrient; useful if fruit/veg intake is inconsistent.

Buy ingredient →

500mg

General health effects / safety

Moderate

Population: General healthy adults

Study type: Government evidence review

Dose context: 500 mg typical (range: 200–1000 mg) • Duration: Varies by outcome

ODS health professional fact sheet summarizes evidence, dosing, and safety/UL (2,000 mg/day).

Citation: NIH ODS – Vitamin C: Health Professional Fact Sheet•https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/

Common cold duration and severity

Moderate

Population: General adults; greater effect seen in people under heavy physical stress

Study type: Cochrane systematic review and meta-analysis

Dose context: 1000 mg typical (range: 200–1000 mg) • Duration: Continuous daily supplementation

Cochrane review of regular vitamin C supplementation (≥200 mg/day) found a consistent ~8% reduction in cold duration in adults and ~14% in children, with no effect on cold incidence in the general population. Therapeutic use at cold onset showed no consistent benefit.

Citation: Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980.•DOI: 10.1002/14651858.CD000980.pub4•https://pubmed.ncbi.nlm.nih.gov/23440782/

ZincModerate

With food • Capsule • Click to expand

Micronutrient support; avoid chronic high-dose without copper consideration.

Buy ingredient →

15mg

Recommended intakes / safety / interactions

Moderate

Population: General population

Study type: Government evidence review

Dose context: 15 mg typical (range: 10–25 mg) • Duration: Daily / as needed

ODS fact sheet summarizes intakes, deficiency, and risks from excess zinc.

Citation: NIH ODS – Zinc: Health Professional Fact Sheet•https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/

Common cold duration

Moderate

Population: Adults with naturally acquired common cold

Study type: Meta-analysis of RCTs

Dose context: 80 mg typical (range: 75–150 mg) • Duration: Duration of illness

Meta-analysis of 7 placebo-controlled trials (zinc lozenges >75 mg/day) found cold duration was 33% shorter in zinc groups overall; zinc acetate lozenges reduced duration by 40% and zinc gluconate by 28%. No benefit was seen from doses above 100 mg/day.

Citation: Hemilä H. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. 2017;8(5):2054270417694291.•DOI: 10.1177/2054270417694291•https://pubmed.ncbi.nlm.nih.gov/28515951/